Identification of the Imidazo[1,2-<i>a</i>]pyrazine Derivative <b>A4</b> as a Potential Influenza Virus Nucleoprotein Inhibitor-Reference-Cited by-同舟云学术

Identification of the Imidazo[1,2-a]pyrazine Derivative A4 as a Potential Influenza Virus Nucleoprotein Inhibitor

Published:2023-11-17 Issue:12 Volume:6 Page:1841-1850
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Li Ping¹²,Ju Han¹³,Xing Yihong³,Zhao Fabao¹^ORCID,Anirudhan Varada⁴,Du Ruikun²,Cui Qinghua²,Liu Xinyong¹^ORCID,Rong Lijun⁴,Zhan Peng¹^ORCID

Affiliation:

1. Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan 250012, China

2. Innovation Research Institute of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China

3. State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Xue Yuan Rd. 38, Beijing 100191, China

4. Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, United States

Funder

China Postdoctoral Science Foundation

Natural Science Foundation of Shandong Province

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.3c00174

Reference36 articles.

1. Overview of Influenza Viruses

2. A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases

3. Seasonal and pandemic influenza: 100 years of progress, still much to learn

4. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance

5. Circulation, Evolution and Transmission of H5N8 virus, 2016–2018